Articles with public access mandates - Alice H. BergerLearn more
Not available anywhere: 2
BCR-ABL disrupts PTEN nuclear-cytoplasmic shuttling through phosphorylation-dependent activation of HAUSP
A Morotti, C Panuzzo, S Crivellaro, B Pergolizzi, U Familiari, AH Berger, ...
Leukemia 28 (6), 1326-1333, 2014
Mandates: US National Institutes of Health
Massively parallel phenotyping of coding variants in cancer with Perturb-seq
O Ursu, JT Neal, E Shea, PI Thakore, L Jerby-Arnon, L Nguyen, D Dionne, ...
Nature biotechnology 40 (6), 896-905, 2022
Mandates: US National Institutes of Health, Howard Hughes Medical Institute, Chan …
Available somewhere: 34
A next generation connectivity map: L1000 platform and the first 1,000,000 profiles
A Subramanian, R Narayan, SM Corsello, DD Peck, TE Natoli, X Lu, ...
Cell 171 (6), 1437-1452. e17, 2017
Mandates: US National Institutes of Health
Oncogenic signaling pathways in the cancer genome atlas
F Sanchez-Vega, M Mina, J Armenia, WK Chatila, A Luna, KC La, ...
Cell 173 (2), 321-337. e10, 2018
Mandates: US National Institutes of Health
Mapping the hallmarks of lung adenocarcinoma with massively parallel sequencing
M Imielinski, AH Berger, PS Hammerman, B Hernandez, TJ Pugh, ...
Cell 150 (6), 1107-1120, 2012
Mandates: US National Institutes of Health, Canadian Institutes of Health Research …
Distinct patterns of somatic genome alterations in lung adenocarcinomas and squamous cell carcinomas
JD Campbell, A Alexandrov, J Kim, J Wala, AH Berger, CS Pedamallu, ...
Nature genetics 48 (6), 607-616, 2016
Mandates: US National Institutes of Health
A continuum model for tumour suppression
AH Berger, AG Knudson, PP Pandolfi
Nature 476 (7359), 163-169, 2011
Mandates: US National Institutes of Health
Institutional implementation of clinical tumor profiling on an unselected cancer population
LM Sholl, K Do, P Shivdasani, E Cerami, AM Dubuc, FC Kuo, EP Garcia, ...
JCI insight 1 (19), 2016
Mandates: US National Institutes of Health
Functional analysis of receptor tyrosine kinase mutations in lung cancer identifies oncogenic extracellular domain mutations of ERBB2
H Greulich, B Kaplan, P Mertins, TH Chen, KE Tanaka, CH Yun, X Zhang, ...
Proceedings of the National Academy of Sciences 109 (36), 14476-14481, 2012
Mandates: US National Institutes of Health
High-throughput phenotyping of lung cancer somatic mutations
AH Berger, AN Brooks, X Wu, Y Shrestha, C Chouinard, F Piccioni, ...
Cancer cell 30 (2), 214-228, 2016
Mandates: US National Institutes of Health, Damon Runyon Cancer Research Foundation
Identification of DOK genes as lung tumor suppressors
AH Berger, M Niki, A Morotti, BS Taylor, ND Socci, A Viale, C Brennan, ...
Nature genetics 42 (3), 216-223, 2010
Mandates: US National Institutes of Health
Oncogenic RIT1 mutations in lung adenocarcinoma
AH Berger, M Imielinski, F Duke, J Wala, N Kaplan, GX Shi, DA Andres, ...
Oncogene 33 (35), 4418-4423, 2014
Mandates: US National Institutes of Health
RNA isoform screens uncover the essentiality and tumor-suppressor activity of ultraconserved poison exons
JD Thomas, JT Polaski, Q Feng, EJ De Neef, ER Hoppe, MV McSharry, ...
Nature genetics 52 (1), 84-94, 2020
Mandates: US National Institutes of Health
Discovery of synthetic lethal and tumor suppressor paralog pairs in the human genome
PCR Parrish, JD Thomas, AM Gabel, S Kamlapurkar, RK Bradley, ...
Cell reports 36 (9), 2021
Mandates: US National Science Foundation, US Department of Defense, US National …
MET exon 14 mutation encodes an actionable therapeutic target in lung adenocarcinoma
X Lu, N Peled, J Greer, W Wu, P Choi, AH Berger, S Wong, KY Jen, Y Seo, ...
Cancer research 77 (16), 4498-4505, 2017
Mandates: US National Institutes of Health, Doris Duke Charitable Foundation
Recommendations for the collection and use of multiplexed functional data for clinical variant interpretation
H Gelman, JN Dines, J Berg, AH Berger, S Brnich, FM Hisama, RG James, ...
Genome Medicine 11, 1-11, 2019
Mandates: US National Institutes of Health
Suppression of CHK1 by ETS Family Members Promotes DNA Damage Response Bypass and Tumorigenesis
A Lunardi, S Varmeh, M Chen, R Taulli, J Guarnerio, U Ala, N Seitzer, ...
Cancer discovery 5 (5), 550-563, 2015
Mandates: US National Institutes of Health
Brain angiogenesis inhibitor 1 is expressed by gastric phagocytes during infection with Helicobacter pylori and mediates the recognition and engulfment of human apoptotic …
S Das, A Sarkar, KA Ryan, S Fox, AH Berger, IJ Juncadella, D Bimczok, ...
The FASEB Journal 28 (5), 2214, 2014
Mandates: US National Institutes of Health
Loss of MGA repression mediated by an atypical polycomb complex promotes tumor progression and invasiveness
H Mathsyaraja, J Catchpole, B Freie, E Eastwood, E Babaeva, ...
Elife 10, e64212, 2021
Mandates: US National Institutes of Health, Lung Cancer Research Foundation, USA …
Cell Painting predicts impact of lung cancer variants
JC Caicedo, J Arevalo, F Piccioni, MA Bray, CL Hartland, X Wu, ...
Molecular biology of the cell 33 (6), ar49, 2022
Mandates: US National Institutes of Health
Publication and funding information is determined automatically by a computer program